Adipokines and the blood-brain barrier

Peptides

Volumn 28, Issue 6, 2007, Pages 1317-1330

  Pan, Weihong ^a   Kastin, Abba J ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

Adipocytes; Adipokines; Adiponectin; Angiotensinogen; ASP; Blood brain barrier; Cytokines; IL 6; Leptin; PAI 1; Peptides; Polypeptides; RBP; Relaxin; Resistin; TGF ; TNF

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ANGIOTENSINOGEN; INTERLEUKIN 6; LEPTIN RECEPTOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN OBRE; RELAXIN; RESISTIN; TRACER; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UROCORTIN;

BLOOD BRAIN BARRIER; CELL MEMBRANE PERMEABILITY; CEREBROSPINAL FLUID; ENDOTHELIUM CELL; HUMAN; INSULIN RESISTANCE; METABOLIC SYNDROME X; MICROARRAY ANALYSIS; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN SYNTHESIS; RECEPTOR UPREGULATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; STROKE; WEIGHT REDUCTION;

ADIPOCYTES; ADIPONECTIN; ADIPOSE TISSUE, WHITE; ANIMALS; BLOOD-BRAIN BARRIER; HUMANS; INTERLEUKIN-6; LEPTIN; PEPTIDES; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34249717231     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2007.04.023     Document Type: Review

References (137)

1. Ahima R., Qi Y., Singhal N., Jackson M., and Scherer P. Brain adipocytokine action and metabolic regulation. Diabetes 55 (2006) S145-S154
2. Alessi M., Bastelica D., Morange P., Berthet B., Leduc I., Verdier M., et al. Plasminogen activator inhibitor 1, transforming growth factor-beta 1, and BMI are closely associated in human adipose tissue during morbid obesity. Diabetes 49 (2000) 1374-1380
3. Algrain M., Turunen O., Vaheri A., Louvard D., and Arpin M. Ezrin contains cytoskeleton and membrane binding domains accounting for its proposed role as a membrane-cytoskeletal linker. J Cell Biol 120 (1993) 129-139
4. Arimura A., Inagaki N., Chihara K., Menager C., Nakamura N., Amano M., et al. Phosphorylation of collapsin response mediator protein-2 by Rho-kinase. Evidence for two separate signaling pathways for growth cone collapse. J Biol Chem 275 (2000) 23973-23980
5. Banks W.A. Denial versus dualism: the blood-brain barrier as an interface of the gut-brain axis. Endocrinology 147 (2006) 2609-2610
6. Banks W.A., Clever C.M., and Farrell C.L. Partial saturation and regional variation in the transport of leptin across the blood-brain barrier in normal weight mice. Am J Physiol 278 (2000) E1158-E1165
7. Banks W.A., DiPalma C.R., and Farrell C.L. Impaired transport of leptin across the blood-brain barrier in obesity. Peptides 20 (1999) 1341-1345
8. Banks W.A., Kastin A.J., and Gutierrez E.G. Penetration of interleukin-6 across the murine blood-brain barrier. Neurosci Lett 179 (1994) 53-56
9. Banks W.A., Kastin A.J., Huang W., Jaspan J.B., and Maness L.M. Leptin enters the brain by a saturable system independent of insulin. Peptides 17 (1996) 305-311
10. Banks W.A., Niehoff M.L., Martin D., and Farrell C.L. Leptin transport across the blood-brain barrier of the Koletsky rat is not mediated by a product of the leptin receptor gene. Brain Res 950 (2002) 130-136
11. Barb C., Hausman G., and Czaja K. Leptin: a metabolic signal affecting central regulation of reproduction in the pig. Domest Anim Endocrinol 29 (2005) 186-192
12. Barsacchi R., Perrotta C., Bulotta S., Moncada S., Borgese N., and Clementi E. Activation of endothelial nitric-oxide synthase by tumor necrosis factor-alpha: a novel pathway involving sequential activation of neutral sphingomyelinase, phosphatidylinositol-3′ kinase, and Akt. Mol Pharmacol 63 (2003) 886-895
13. Bastard J., Jardel C., Bruckert E., Blondy P., Capeau J., Laville M., et al. Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab 85 (2000) 3338-3342
14. Bastard J., Maachi M., Van Nhieu J., Jardel C., Bruckert E., Grimaldi A., et al. Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J Clin Endocrinol Metab 87 (2002) 2084-2089
15. Begley D.J. Peptides and the blood-brain barrier: the status of our understanding. Ann N Y Acad Sci 739 (1994) 89-100
16. Benchenane K., Berezowski V., Ali C., Fernandez-Monreal M., Lopez-Atalaya J., Brillaut J., et al. Tissue-type plasminogen activator crosses the intact blood-brain barrier by low-density lipoprotein receptor-related protein-mediated transcytosis. Circulation 111 (2005) 2241-2249
17. Birgel M., Gottschling-Zeller H., Hrohrig K., and Hauner H. Role of cytokines in the regulation of plasminogen activator inhibitor-1 expression and secretion in newly differentiated subcutaneous human adipocytes. Arterioscler Thromb Vasc Biol 20 (2000) 1682-1687
18. Bjørbæk C., and Kahn B.B. Leptin signaling in the central nervous system and the periphery. Recent Prog Horm Res 59 (2004) 305-331
19. Bjørbæk C., Elmquist J.K., Michl P., Ahima R.S., van Bueren A., McCall A.L., et al. Experession of leptin receptor isoforms in rat brain microvessels. Endocrinology 139 (1998) 3485-3491
20. Browne G., and Proud C. Regulation of peptide-chain elongation in mammalian cells. Eur J Biochem 269 (2002) 5360-5368
21. Cardone M., and Mostov K. Wortmannin inhibits transcytosis of dimeric IgA by the polymeric immunoglobulin receptor. FEBS Lett 376 (1995) 74-76
22. Caro J.F., Kolaczynski J.W., Nyce M.R., Ohannesian J.P., Opentanova I., Goldman W.H., et al. Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 348 (1996) 159-161
23. Carswell E.A., Old L.J., and Dassel R.L. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 72 (1975) 3666-3670
24. Cianflone K., Lu H., Smith J., Yu W., and Wang H. Adiponectin, acylation stimulating protein and complement C3 are altered in obesity in very young children. Clin Endocrinol 62 (2005) 567-572
25. Defacque H., Boes E., Garvalov B., Barret C., Roy C., Mangeat P., et al. Phosphoinositides regulate membrane-dependent actin assembly by latex bead phagosomes. Mol Biol Cell 13 (2002) 1190-1202
26. DeMartino G., and Slaughter C. The proteasome, a novel protease regulated by multiple mechanisms. J Biol Chem 274 (1999) 22123-22126
27. Dhillon H., Zigman J.M., Ye C.P., Lee C.E., McGovern R.A., Tang V.S., et al. Leptin directly activates SF1 neurons in the VMH, and this action by leptin is required for normal body-weight homeostasis. Neuron 49 (2006) 191-203
28. Di Simone N., Di Nicuolo F., Sanguinetti M., Castellani R., D'Asta M., Caforio L., et al. Resistin regulates human choriocarcinoma cell invasive behaviour and endothelial cell angiogenic processes. J Endocrinol 189 (2006) 691-699
29. Dohgu S., Yamauchi A., Takata F., Naito M., Tsuruo T., Higuchi S., et al. Transforming growth factor-beta-1 upregulates the tight junction and P-glycoprotein of brain microvascular endothelial cells. Cell Mol Neurobiol 24 (2004) 491-497
30. Fain J., Tichansky D., and Madan A. Transforming growth factor beta 1 release by human adipose tissue is enhanced in obesity. Metabolism 54 (2005) 1546-1551
31. Friedman J.M. Obesity in the new millennium. Nature 404 (2000) 632-634
32. Fry M., Smith P., Hoyda T., Duncan M., Ahima R., Sharkey K., et al. Area postrema neurons are modulated by the adipocyte hormone adiponectin. J Neurosci 26 (2006) 9695-9702
33. Goossens G., Jocken J., Blaak E., Schiffers P., Saris W., and van Baak M. Endocrine role of the renin-angiotensin system in human adipose tissue and muscle. Effect of beta-adrenergic stimulation. Hypertension 49 (2007) 542-547
34. Gu Y., and Ihara Y. Evidence that collapsin response mediator protein-2 is involved in the dynamics of microtubules. J Biol Chem 275 (2000) 17917-17920
35. Halaas J., Boozer C., Blair-West J., Fidahusein N., Denton D.A., and Friedman J.M. Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc Natl Acad Sci USA 94 (1997) 8878-8883
36. Harvey J., and Ashford M. Leptin in the CNS: much more than a satiety signal. Neuropharmacology 44 (2003) 845-854
37. Houle F., Rousseau S., Morrice N., Luc M., Mongrain S., Turner C., et al. Extracellular signal-regulated kinase mediates phosphorylation of tropomyosin-1 to promote cytoskeleton remodeling in response to oxidative stress: impact on membrane blebbing. Mol Biol Cell 14 (2003) 1418-1432
38. Janke J., Engeli S., Boschmann M., Adams F., Bohnke J., Luft F., et al. Retinol-binding protein 4 in human obesity. Diabetes 55 (2006) 2805-2810
39. Johanson C.A.E. Ventricles, cerebrospinal fluid. In: Conn P.M. (Ed). Neuroscience in Medicine (1995), J.B. Lippincott, Philadelphia 171-196
40. Johanson C.E. The choroid plexus-CNF nexus. In: Conn P.M. (Ed). Neuroscience in medicine, (2003), Humana Press Inc., Totowa, NJ 165-195
41. Kakinuma Y., Hama H., Sugiyama F., Yagami K., Goto K., Murakami K., et al. Impaired blood-brain barrier function in angiotensinogen-deficient mice. Nat Med 4 (1998) 1078-1080
42. Kaminde K., Rakugi H., Nagai M., Takiuchi S., Matsukawa N., Higaki J., et al. Insulin-mediated regulation of the endothelial renin-angiotensin system and vascular cell growth. J Hypertens 22 (2004) 121-127
43. Kartmann B., and Roth D. Novel roles for mammalian septins: from vesicle trafficking to oncogenesis. J Cell Sci 114 (2001) 839-844
44. Kasai K., and Akagawa K. Roles of the cytoplasmic and transmembrane domains of syntaxins in intracellular localization and trafficking. J Cell Sci 114 (2001) 3115-3124
45. Kastin A.J., and Akerstrom V. Fasting, but not adrenalectomy, reduces transport of leptin into the brain. Peptides 21 (2000) 679-682
46. Kastin A.J., and Akerstrom V. Glucose and insulin increase the transport of leptin through the blood-brain barrier in normal mice but not in streptozotocin-diabetic mice. Neuroendocrinology 73 (2001) 237-242
47. Kastin A.J., Akerstrom V., and Pan W. Circulating TGF beta 1 does not cross the intact blood-brain barrier. J Mol Neurosci 21 (2003) 43-48
48. Kastin A.J., Akerstrom V., and Pan W. Activation of urocortin transport into brain by leptin. Peptides 21 (2000) 1811-1818
49. Kastin A.J., Banks W.A., Ahmed B., and Zadina J.E. Influence of hormones and messenger peptides on normal brain function. Principles and practice of endocrinology & metabolism (1995), J.B. Lippincott, Philadelphia pp. 1682-1691
50. Kastin A.J., and Pan W. Editorial: intranasal leptin: blood-brain barrier bypass (BBBB) for obesity?. Endocrinology 147 (2006) 2086-2087
51. Kastin A.J., Pan W., Akerstrom V., Hackler L., Wang C., and Kotz C.M. Novel peptide-peptide cooperation may transform feeding behavior. Peptides 23 (2002) 2189-2196
52. Kastin A.J., Pan W., Zadina J.E., and Banks WA. The endocrine brain. In: Becker K.L. (Ed). Principles and practice of endocrinology and metabolism (2001), Lippincott Willimas & Wilkins, Philadelphia 1611-1615
53. Kastin A.J., Pan W., Maness L.M., and Banks W.A. Peptides crossing the blood-brain barrier: some unusual observations. Brain Res 848 (1999) 96-100
54. Kastin A.J., Pan W., Maness L.M., Koletsky R.J., and Ernsberger P. Decreased transport of leptin across the blood-brain barrier in rats lacking the short form of the leptin receptor. Peptides 20 (1999) 1449-1453
55. Kastin AJ, Zadina JE, Olson RD, Banks WA. The history of neuropeptide research: version 5.a. In: Crawley, JN, McLean, S, editors. Neuropeptides: Basic and Clinical Advances, New York: Ann NY Acad Sci; 1996, p. 1-18.
56. Knebel A., Haydon C., Morrice N., and Cohen P. Stress-induced regulation of eukaryotic elongation factor 2 kinase by SB 203580-sensitive and -insensitive pathways. Biochem J 367 (2002) 525-532
57. Kos K., Harte A., da Silva N., Tontchev A., Chalakov G., James S., et al. Adiponectin and resistin in human cerebrospinal fluid and expression of adiponectin receptors in the human hypothalamus. J Clin Endocrinol Metab 92 (2007) 1129-1136
58. Kossmann T., Stahel P., Morganti-Kossmann M., Jones J., and Barnum S. Elevated levels of the complement components C3 and factor B in ventricular cerebrospinal fluid of patients with traumatic brain injury. J Neuroimmunol 73 (1997) 63-69
59. Kroder G., Bossenmaier B., Kellerer M., Capp E., Stoyanov B., Muhlhofer A., et al. Tumor necrosis factor-alpha- and hyperglycemia-induced insulin resistance. Evidence for different mechanisms and different effects on insulin signalling. J Clin Invest 97 (1996) 1471-1477
60. Kusminski C., McTernan P., Schraw T., Kos K., O'hare J., Ahima R., et al. Adiponectin complexes in human cerebrospinal fluid: distinct complex distribution from serum. Diabetologia 50 (2007) 634-642
61. Le Lay S., Boucher J., Rey A., Castan-Laurell I., Krief S., Ferre P., et al. Decreased resistin expression in mice with different sensitivities to a high-fat diet. Biochem Biophys Res Commun 289 (2001) 564-567
62. Lijnen H., Maquoi E., Morange P., Voros G., Van Hoef B., Kopp F., et al. Nutritionally induced obesity is attenuated in transgenic mice overexpressing plasminogen activator inhibitor-1. Arterioscler Thromb Vasc Biol 23 (2003) 78-84
63. Lin S., Gundersen G., and Maxfield F. Export from pericentriolar endocytic recycling compartment to cell surface depends on stable, detyrosinated (glu) microtubules and kinesin. Mol Biol Cell 13 (2002) 96-109
64. Loeffler D., Brickman C., Juneau P., Perry M., Pomara N., and Lewitt P. Cerebrospinal fluid C3a increases with age, but does not increase further in Alzheimer's disease. Neurobiol Aging 18 (1997) 555-557
65. MacDonald P., Bok D., and Ong D. Localization of cellular retinol-binding protein and retinol-binding protein in cells comprising the blood-brain barrier of rat. Proc Natl Acad Sci USA 87 (1989) 4265-4269
66. Madge L.A., and Pober J.S. A phosphatidylinositol 3-kinase/Akt pathway, activated by tumor necrosis factor or interleukin-1, inhibits apoptosis but does not activate NFkappaB in human endothelial cells. J Biol Chem 275 (2000) 15458-15465
67. Maresh G.A., Maness L.M., Zadina J.E., and Kastin A.J. In vitro demonstration of a saturable transport system for leptin across the blood-brain barrier. Life Sci 69 (2001) 67-73
68. Mario M., Dunbar J., Wu L., Ngaiza J., Han H., Guo D., et al. Inhibition of tumor necrosis factor signal transduction in endothelial cells by dimethylaminopurine. J Biol Chem 271 (1996) 28624-28629
69. Massiera F., Seydoux J., Geloen A., Quignard-Boulange A., Turban S., Saint-Marc P., et al. Angiotensin-deficient mice exhibit impairment of diet-induced weight gain with alteration in adipose tissue development and increased locomotor activity. Endocrinology 142 (2001) 5220-5225
70. Mayrand S., Dwen P., and Pederson T. Serine/threonine phosphorylation regulates binding of C hnRNP proteins to pre-mRNA. Proc Natl Acad Sci USA 90 (1993) 7764-7768
71. McCarty M. De novo synthesis of diacylglycerol in enothelium may mediate the association between PAI-1 and the insulin resistance syndrome. Med Hypotheses 64 (2005) 388-393
72. McGowan B., Stanley S., Smith K., White N., Connolly M., Thompson E., et al. Central relaxin-3 administration causes hyperphagia in male Wistar rats. Endocrinology 146 (2005) 3295-3300
73. McLennan I., Weible M2, Hendry I., and Koishi K. Transport of transforming growth factor-beta 2 across the blood-brain barrier. Neuropharmacology 48 (2005) 274-282
74. Morange P., Lijnen H., Alessi M., Kopp F., Collen D., and Juhan-Vague I. Influence of PAI-1 on adipose tissue growth and metabolic parameters in a murine model of diet-induced obesity. Arterioscler Thromb Vasc Biol 20 (2000) 1150-1154
75. Mullock B., SMith C., Ihrke G., Bright N., Lindsay M., Parkinson E., et al. Syntaxin 7 is localized to late endosome compartments, associates with Vamp 8, and is required for late endosome-lysosome fusion. Mol Biol Cell 11 (2000) 3137-3153
76. Murray I., Havel P., Sniderman A., and Cianflone K. Reduced body weight, adipose tissue, and leptin levels despite increased energy intake in female mice lacking acylation-stimulating protein. Endocrinology 141 (2000) 1041-1049
77. Nagai N., Suzuki Y., Van Hoef B., Lijnen H., and Collen D. Effects of plasminogen activator inhibitor-1 on ischemic brain injury in permanent and thrombotic middle cerebral artery occlusion models in mice. J Thromb Haemost 3 (2005) 1379-1384
78. Palombella V., Rando O., Goldberg A., and Maniatis T. The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B. Cell 78 (1994) 773-785
79. Pan W., Ding Y., Yu Y., Ohtaki H., Nakamichi T., and Kastin A.J. Stroke upregulates TNF alpha transport across the blood-brain barrier. Exp Neurol 198 (2006) 222-233
80. Pan W., and Kastin A.J. Increase in TNFα transport after SCI is specific for time, region and type of lesion. Exp Neurol 170 (2001) 357-363
81. Pan W., and Kastin A.J. TNFα transport across the blood-brain barrier is abolished in receptor knockout mice. Exp Neurol 174 (2002) 193-200
82. Pan W., and Kastin A.J. Why study transport of peptides and proteins at the neurovascular interface. Brain Res Rev 46 (2004) 32-43
83. Pan W., Kastin A.J., Rigai T., McLay R.N., and Pick C.G. Increased hippocampal uptake of tumor necrosis factor α and behavioral changes in mice. Exp Brain Res 149 (2003) 195-199
84. Pan W, Tu H, Hsuchou H, Daniel J, Kastin AJ. Amplification of leptin-induced Stat3 signaling by urocortin. Mol Endocrinol, in press.
85. Pan W, Tu H, Hsuchou H, Yang Y, Kastin AJ. Differential role of TNF receptors in cellular trafficking of intact TNF. Cell Physiol Biochem, in press.
86. Pan W., Tu H., and Kastin A.J. Differential BBB interactions of three ingestive peptides: obestatin, ghrelin, and adiponectin. Peptides 27 (2006) 911-916
87. Pan W., Zhang L., Liao J., Csernus B., and Kastin A.J. Selective increase in TNF alpha permeation across the blood-spinal cord barrier after SCI. J Neuroimmunol 134 (2003) 111-117
88. Pan W., Banks W.A., and Kastin A.J. Blood-brain barrier permeability to ebiratide and TNF in acute spinal cord injury. Exp Neurol 146 (1997) 367-373
89. Pan W., Banks W.A., and Kastin A.J. Permeability of the blood-brain barrier to neurotrophins. Brain Res 788 (1998) 87-94
90. Pan W., Banks W.A., Kennedy M.K., Gutierrez E.G., and Kastin A.J. Differential permeability of the BBB in acute EAE: enhanced transport of TNF-α. Am J Physiol 34 (1996) E636-E642
91. Pan W., Cornelissen G., Halberg F., and Kastin A.J. Selected contribution: circadian rhythm of tumor necrosis factor-alpha uptake into mouse spinal cord. J Appl Physiol 92 (2002) 1357-1362
92. Pan W., Csernus B., and Kastin A.J. Upregulation of p55 and p75 receptors mediating TNF alpha transport across the injured blood-spinal cord barrier. J Mol Neurosci 21 (2003) 173-184
93. Pan W., and Kastin A.J. Diurnal variation of leptin entry from blood to brain involving partial saturation of the transport system. Life Sci 68 (2001) 2705-2714
94. Pan W., and Kastin A.J. Upregulation of the transport system for TNFα at the blood-brain barrier. Arch Physiol Biochem 109 (2001) 350-353
95. Pan W., and Kastin A.J. Interactions of cytokines with the blood-brain barrier: implications for feeding. Curr Pharm Des 9 (2003) 827-831
96. Pan W., and Kastin A.J. Transport of cytokines and neurotrophins across the BBB and their regulation after spinal cord injury. In: Shanker H., and Westman J. (Eds). Blood-spinal cord and brain barriers in health and disease (2003), Elsevier, Academic Press, San Diego, CA 395-407
97. Pan W., Kastin A.J., Bell R.L., and Olson R.D. Upregulation of tumor necrosis factor alpha transport across the blood-brain barrier after acute compressive spinal cord injury. J Neurosci 19 (1999) 3649-3655
98. Pan W., Kastin A.J., Daniel J., Yu C., Baryshnikova L.M., and von Bartheld C.S. TNF alpha trafficking in cerebral vascular endothelial cells. J Neuroimmunol 185 (2007) 47-56
99. Peruzzo B., Pastor F.E., Blazquez J.L., Schobitz K., Pelaez B., Amat P., et al. A second look at the barriers of the medial basal hypothalamus. Exp Brain Res 132 (2000) 10-26
100. Plotkin S.R., Banks W.A., and Kastin A.J. Comparison of saturable transport and extracellular pathways in the passage of interleukin-1α across the blood-brain barrier. J Neuroimmunol 67 (1996) 41-47
101. Pradillo J., Romera C., Hurtado O., Cardenas A., Moro M., Leza J., et al. TNFR1 upregulation mediates tolerance after brain ischemic preconditioning. J Cereb Blood Flow Metab 25 (2005) 193-203
102. Qi Y., Takahashi N., Hileman S.M., Patel H., Berg A.H., Pajvani U.B., et al. Adiponectin acts in the brain to decrease body weight. Nat Med 10 (2004) 524-529
103. Quattrone S., Chiappini L., Scapagnini G., Bigazzi B., and Bani D. Relaxin potentiates the expression of inducible nitric oxide synthase by endothelial cells from human umbilical vein in in vitro culture. Mol Hum Reprod 10 (2004) 325-330
104. Ramsey J.J., Kemnitz J.W., Colman R.J., Cunningham D., and Swick A.G. Different central and peripheral responses to leptin in rhesus monkeys: brain transport may be limited. J Clin Endocrinol Metab 83 (1998) 3230-3235
105. Rousseau S., Morrice N., Peggie M., Campbell D., Gaestel M., and Cohen P. Inhibition of SAPK2a/p38 prevents hnRNP A0 phosphorylation by MAPKAP-K2 and its interaction with cytokine mRNAs. EMBO J 21 (2002) 6505-6514
106. Schafer K., Fujisawa K., Konstantinides S., and Loskutoff D. Disruption of the plasminogen activator inhibitor 1 gene reduces the adiposity and improves the metabolic profile of genetically obese and diabetic ob/ob mice. FASEB J 15 (2001) 1840-1842
107. Schwartz M.W., Peskind E., Raskind M., Boyko E.J., and Porte Jr. D. Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans. Nat Med 2 (1996) 589-593
108. Skilton M., Nakhla S., Sieveking D., Caterson I., and Celermajer D. Pathophysiological levels of the obesity related peptides resistin and ghrelin increase adhesion molecule expression on human vascular endothelial cells. Clin Exp Pharmacol Physiol 32 (2005) 839-844
109. Sniderman A., Cianflone K., and Eckel R. Levels of acylation stimulating protein in obese women before and after moderate weight loss. Int J Obes 15 (1991) 333-336
110. Sporer B., Koedel U., Popp B., Paul R., and Pfister H. Evaluation of cerebrospinal fluid uPA, PAI-1, and soluble uPAR levels in HIV-infected patients. J Neuroimmunol 163 (2005) 190-194
111. Spranger J., Verma S., Gohring I., Bobbert T., Seifert J., Sindler A., et al. Adiponectin does not cross the blood-brain barrier but modifies cytokine expression of brain endothelial cells. Diabetes 55 (2006) 141-147
112. Stenlof K., Wernstedt I., Fjallman T., Wallenius V., Wallenius K., and Jansson J. Interleukin-6 levels in the central nervous system are negatively correlated with fat mass in overweight/obese subjects. J Clin Endocrinol Metab 88 (2003) 4379-4383
113. Steppan C., Bailey S., Bhat S., Brown E., Banerjee R., Wright C., et al. The hormone resistin links obesity to diabetes. Nature 409 (2001) 307-312
114. Strand F.L. Neuropeptides: regulators of physiological processes (1999), MIT Press, Cambridge, MA p. 89
115. Sun D., Lytle C., and O'Donnell M. IL-6 secreted by astroglial cells regulates Na-K-Cl cotransport in brain microvessel endothelial cells. Am J Physiol 272 (1997) C1829-C1835
116. Sunn N., Egli M., Burazin T., Burns P., Colvill L., Davern P., et al. Circulating relaxin acts on subfornical organ neurons to stimulate water drinking in the rat. Proc Natl Acad Sci USA 99 (2002) 1701-1706
117. Takata F., Dohgu S., Yamauchi A., Sumi N., Nakagawa S., Naito M., et al. Inhibition of transforming growth factor-beta production in brain pericytes contributes to cyclosporin A-induced dysfunction of the blood-brain barrier. Cell Mol Neurobiol 27 (2007) 317-328
118. Torti F., Torti S., Larrick J., and Ringold G. Modulation of adipocyte differentiation by tumor necrosis factor and transforming growth factor beta. J Cell Biol 108 (1989) 1105-1113
119. Traenckner E., Wilk S., and Baeuerle P. A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF-kappa B. EMBO J 13 (1994) 5433-5441
120. Tsutsumi C., Okuno M., Tannous L., Piantedosi R., Allan M., Goodman D., et al. Retinoids and retinoid-binding protein expression in rat adipocytes. J Biol Chem 267 (1992) 1805-1810
121. Tu H., Kastin A.J., Bjorbaek C., and Pan W. Urocortin trafficking in cerebral microvessel endothelial cells. J Mol Neurosci 31 (2007) 171-182
122. Tu H, Kastin AJ, Hsuchou H, Pan W. The soluble receptor ObRe inhibits leptin transport. J Cell Physiol, in press.
123. Tu H., Kastin A.J., and Pan W. CRH-R1 and CRH-R2 are both trafficking and signaling receptors for urocortin. Mol Endocrinol 21 (2007) 700-711
124. Tu H., Pan W., Feucht L., and Kastin A.J. Convergent trafficking pattern of leptin after endocytosis mediated by ObRa-ObRd. J Cell Physiol 212 (2007) 215-222
125. Van Heek M., Compton D.S., France C.F., Tedesco R.P., Fawzi A.B., Graziano M.P., et al. Diet-induced obese mice develop peripheral, but not central, resistance to leptin. J Clin Invest 99 (1997) 385-390
126. Verma S., Li S.-H., Wang C.-H., Fedak P.W.M., Li R.-K., Weisel R., et al. Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation 108 (2003) 736-740
127. Walker E., Perisic O., Ried C., Stephens L., and Williams R. Structural insights into phosphoinositide 3-kinase catalysis and signalling. Nature 402 (1999) 313-320
128. Wallenius K., Wallenius V., Sunter D., Dickson S., and Jansson J. Intracereboventricular interleukin-6 treatment decreases body fat in rats. Biochem Biophys Res Commun 293 (2002) 560-565
129. Way J., Gorgun C., Tong Q., Uysal K., Brown K., Harrington W., et al. Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists. J Biol Chem 276 (2001) 25651-25653
130. Wernstedt I., Olsson B., Jernas M., Paglialunga S., Carlsson L., Smith U., et al. Increased levels of acylation-stimulating protein in interleukin-6-deficient (IL-6(-/-)) mice. Endocrinology 147 (2006) 2690-2695
131. Wu-Peng X.S., Chua Jr. S.C., Okada N., Liu S.-M., Nicolson M., and Leibel R.L. Phenotype of obese Koletsky (f) rat due to Tyr763 stop mutation in the extracellular domain of the leptin receptor (lepr). Diabetes 46 (1997) 513-518
132. Yanai K., Saito T., Kakinuma Y., Kon Y., Hirota K., Taniguchi-Yanai K., et al. Renin-dependent cadiovascular functions and renin-independent blood-brain barrier functions revealed by renin-deficient mice. J Biol Chem 275 (2000) 5-8
133. Yang H., Zhang R., Mu H., Li M., Yao Q., and Chen C. Adiponectin promotes endothelial cell differentiation form human peripheral CD14+ monocytes in vitro. J Cell Mol Med 10 (2006) 459-469
134. Yu C, Pan W, Tu H, Waters S, Kastin AJ. TNF activates MDR1 in cerebral microvascular endothelial cells. Cell Physiol Biochem, in press.
135. Yu C, Kastin AJ, Pan W. TNF reduces LIF endocytosis despite increasing NFκB-mediated gp130 expression. J Cell Physiol, in press.
136. Yu C, Kastin AJ, Tu H, Pan W. Opposing effects of proteasomes and lysosomes on LIFR: modulation by TNF. J Mol Neurosci, in press.
137. Zlokovic B.V. Cerebrovascular permeability to peptides: manipulations of transport systems at the blood-brain barrier. Pharm Res 12 (1995) 1395-1406